Doctors abandon a diagnosis used to justify police custody deaths. It might live on, anyway.

Patients living in more disadvantaged neighborhoods were more likely to leave their prescriptions for standard heart failure medications unfilled, retrospective data from a large health

Adding atezolizumab (Tecentriq) to carboplatin improved progression-free survival (PFS) and overall survival (OS) in patients with metastatic triple-negative breast cancer (TNBC), according to results of

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes